https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-20 / PLoS ONE 2011 Apr;6(4):e18801
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-20 / PLoS ONE 2011 Apr;6(4):e188012011-04-20 00:00:002019-02-15 08:53:13Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-18 / Mol. Ther. 2011 Apr;19(4):797-804
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-18 / Mol. Ther. 2011 Apr;19(4):797-8042011-01-18 00:00:002011-01-18 00:00:00Oncolytic virus-initiated protective immunity against prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-04 / Int J Hyperthermia 2011;27(1):63-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-04 / Int J Hyperthermia 2011;27(1):63-732011-01-04 00:00:002019-02-15 10:00:33KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Drugs 2011 Jan;71(1):101-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Drugs 2011 Jan;71(1):101-82011-01-01 00:00:002019-02-15 08:52:53Sipuleucel-T: in metastatic castration-resistant prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-04 / Clin. Dev. Immunol. 2010;2010:517493
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-04 / Clin. Dev. Immunol. 2010;2010:5174932010-11-04 00:00:002019-02-15 08:52:55Dendritic cell-based immunotherapy for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-01 / Neoplasia 2010 Nov;12(11):906-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-01 / Neoplasia 2010 Nov;12(11):906-142010-11-01 00:00:002019-02-15 08:52:56RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-30 / Cancer 2011 Feb;117(3):510-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-30 / Cancer 2011 Feb;117(3):510-62010-09-30 00:00:002019-02-15 10:00:34Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-21 / Int J Hyperthermia 2010;26(8):748-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-21 / Int J Hyperthermia 2010;26(8):748-642010-09-21 00:00:002019-02-15 10:00:35Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-01 / PLoS ONE 2010 Sep;5(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-01 / PLoS ONE 2010 Sep;5(9)2010-09-01 00:00:002019-02-15 08:52:57Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-08-01 / Zhonghua Nan Ke Xue 2010 Aug;16(8):698-704
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-08-01 / Zhonghua Nan Ke Xue 2010 Aug;16(8):698-7042010-08-01 00:00:002019-02-15 08:52:54[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]
